• Nenhum resultado encontrado

There is no benefit in the use of postnatal intravenous immunoglobulin for the prevention of relapses of multiple sclerosis: findings from a systematic review and meta-analysis

N/A
N/A
Protected

Academic year: 2019

Share "There is no benefit in the use of postnatal intravenous immunoglobulin for the prevention of relapses of multiple sclerosis: findings from a systematic review and meta-analysis"

Copied!
6
0
0

Texto

Loading

Imagem

Figure 1. Flowchart of study selection for the systematic review and meta-analyses following the strict Preferred Reporting Items  for Systematic Reviews and Meta-Analyses protocol 5 .
Figure 2. Meta-analyses on data referring to the number of relapses per pregnancy during first six months for patients who  received IVIG postpartum versus other therapeutic options or no-treatment control groups.

Referências

Documentos relacionados

20 patients (16%) presented coronary sequels, 9 of which were diagnosed late, including 3 given IVIG after day 10, and 6 given no IVIG. We found no signiicant association between

80 In a summary of the results of four clinical trials of strontium ranelate, three for treatment of osteoporosis 82-86 and one for prevention, 85 2 g/day of strontium

Use of intravenous immunoglobulin and adjunctive therapies in the treatment of primary immunodeficiencies: a working group report of and study by the Primary

Oral ibuprofen versus intravenous ibuprofen or intravenous indomethacin for the treatment of patent ductus arteriosus in preterm infants: a systematic review and meta- analysis.

The probability of attending school four our group of interest in this region increased by 6.5 percentage points after the expansion of the Bolsa Família program in 2007 and

In every type of analysis, pregnancy and delivery were factors associated with the urinary symptoms, regardless of the method of delivery, and that was in direct

Samples of the following four types of leafy vege- tables were collected on three different days at four sites of sale (three local markets and one street market) during spring

PRISMS (Prevention of Relapses and Disability by Interferon Beta-1a Subcutaneously in Multiple Sclerosis) Study Group and the Univer- sity of British Columbia MS/MRI Analysis